- Home
- FTK vs ENGN Comparison
FTK vs ENGN Comparison
Compare FTK & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTK
- ENGN
- Stock Information
- Founded
- FTK 1985
- ENGN 1999
- Country
- FTK United States
- ENGN Canada
- Employees
- FTK N/A
- ENGN N/A
- Industry
- FTK Major Chemicals
- ENGN
- Sector
- FTK Industrials
- ENGN
- Exchange
- FTK Nasdaq
- ENGN Nasdaq
- Market Cap
- FTK 336.2M
- ENGN 321.5M
- IPO Year
- FTK N/A
- ENGN N/A
- Fundamental
- Price
- FTK $11.72
- ENGN $5.97
- Analyst Decision
- FTK Buy
- ENGN Buy
- Analyst Count
- FTK 2
- ENGN 8
- Target Price
- FTK $12.00
- ENGN $21.50
- AVG Volume (30 Days)
- FTK 338.9K
- ENGN 217.5K
- Earning Date
- FTK 11-03-2025
- ENGN 09-11-2025
- Dividend Yield
- FTK N/A
- ENGN N/A
- EPS Growth
- FTK 82.12
- ENGN N/A
- EPS
- FTK 0.43
- ENGN N/A
- Revenue
- FTK $214,211,000.00
- ENGN N/A
- Revenue This Year
- FTK $19.47
- ENGN N/A
- Revenue Next Year
- FTK $11.22
- ENGN N/A
- P/E Ratio
- FTK $26.66
- ENGN N/A
- Revenue Growth
- FTK 21.72
- ENGN N/A
- 52 Week Low
- FTK $4.55
- ENGN $2.65
- 52 Week High
- FTK $16.87
- ENGN $11.00
- Technical
- Relative Strength Index (RSI)
- FTK 47.74
- ENGN 72.82
- Support Level
- FTK $10.95
- ENGN $5.52
- Resistance Level
- FTK $11.69
- ENGN $6.54
- Average True Range (ATR)
- FTK 0.49
- ENGN 0.53
- MACD
- FTK 0.01
- ENGN 0.12
- Stochastic Oscillator
- FTK 40.74
- ENGN 76.64
About FTK Flotek Industries Inc.
Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.